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Highlights 
 Some ayurvedic medicines contain deliberately added metals or arsenic 
 Bioaccessibility of Potentially Toxic Elements can be estimated by extraction with synthetic 
gastric and intestinal media 
 Bioaccessibility strongly depends on the operating conditions adopted 
 Element bioaccessibility decreases when ayurvedic formulations are mixed with butter 
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Abstract 
Some formulations used in ayurvedic medicine are based on herbs deliberately combined with 
arsenic, metals, and minerals. Some of these preparations have been suspected to be harmful to 
health, due to the content of potentially toxic elements (PTE), hence it is very important to value 
the possible risks associated to their consumption. Such risks depend not only on the total PTE 
concentrations, but also on their bioaccessibility, which influences their assimilation. In this work, 
the total concentrations of As, Cr, Cu, Hg, Mn and Pb in nine ayurvedic medicines purchased in 
India were measured. After sample mineralization, concentrations were determined by atomic 
emission or absorption spectroscopy. The results showed the presence of high amounts of As (19-
479,000 mg/Kg), Cu (27-675,000 mg/Kg), Hg (100-15,600 mg/Kg) or Pb (3-248 mg/Kg) in five of 
these products, whereas much smaller amounts (As, ≤ 1.3-19 mg/Kg; Cu, 0.6-3.2 mg/Kg; Hg, ≤ 1.0-
5.3 mg/Kg; Pb, 0.5-1.8 mg/Kg) were present in the other ones. Subsequently, the bioaccessibility of 
PTE was estimated in vitro by extraction into synthetic gastric and intestinal fluids. The effect of 
different operating conditions was assessed. The results obtained show as elements are mainly 
extracted into gastric juices, and the extent of extraction is strongly influenced by the adopted 
conditions. The data were treated with chemometric techniques that helped to visualize the 
differences and similarities among samples. We calculated the daily intake of each PTE from its 
concentration and from the posology of each medicine, and compared it with the maximum 
tolerable intake levels: the intake of As, Cr, Cu and Hg from some products exceeded such limits 
(whose values, expressed in mg/day for a 60 kg individual, are: As, 0.018; Cr, 0.05; Cu, 30; Hg, 
0.034), mainly when total concentrations were considered, but also for some bioaccessible values. 
Our study shows the importance of adopting homogeneous conditions to evaluate bioaccessibility. 
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The availabilty of standard reference materials for ayurvedic medicines on the market would also 
be highly desirable.  
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1. Introduction 
Ayurveda is a major traditional system of Indian medicine that is still being widely used in many 
countries [1]. It advocates the use of both herbal preparations, similar to other ancient medicines 
in the World, and metallic preparations, that are unique in Ayurveda and, to our knowledge, are 
not known elsewhere [2]. In some ayurvedic products, herbs are deliberately combined with 
metals (e.g., mercury, lead, iron, zinc), minerals (e.g. mica) and gems (e.g., pearl) according to 
traditional procedures known as Rasa shastra [3, 4]. Ayurvedic experts have estimated that 35–
40% of the approximately 6000 medicines in the ayurvedic formulary intently contain at least one 
potentially toxic element (PTE). Although the presence of heavy metals is reported among the 
pharmacologic recommendations in or on the packaging for some of these remedies, the specific 
active ingredient is seldom identified and there is little information available to the practitioner or 
patient about the toxicity and safety of the so-called ‘natural’ organic or inorganic ingredients. 
Some metal-based preparations used in Indian system of medicine are suspected to be harmful, 
causing hepatic, renal and neurotoxicity and many other side effects [5], because over recent 
years, an increasing number of published cases deals with patients that have been poisoned by 
heavy metals after the ingestion of traditional remedies. [6-10]. It is relatively easy to determine 
total metal content in ayurvedic formulations either directly, using analytical techniques suitable 
for solid samples (e.g., X-ray fluorescence spectroscopy), or after acid digestion and measurement 
by atomic spectroscopy or mass spectrometry with plasma source. However, the determination of 
the total inorganic content in ayurvedic formulation is not sufficient for understanding the 
chemical risk to humans upon consumption of these preparations: it is important to assess the 
amount of elements potentially available for absorption in the stomach and intestine or to be 
excreted. A medicine, administered orally, undergoes three steps of transformation: i) the 
pharmaceutic step, in which the product is disgregated and the active principle is dissolved in the 
gastrointestinal tract; ii) the pharmacokinetic step, during which the active principles undergo 
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adsorption, distribution, metabolism and excretion (ADME); iii) the pharmacodynamics step, 
involving the interaction between the active principle and the receptor.  
Bioavailability can be defined as the amount of a substance reaching the systemic circulation, and 
is influenced by the chemico-physical characteristics of the substance (e.g. its solubility, 
lipophilicity, or ionization), its morphology (e.g. powder or tablet) and by the conditions of the 
individual. 
In the present study we focused our attention onto the pharmaceutic step and considered 
bioaccessibility, which can be defined as the fraction of a compound that is released from its 
matrix in the gastrointestinal tract and thus becomes available for intestinal absorption (i.e. enters 
the blood stream) [11]. The bioaccessible fraction of a substance includes both the actually and 
potentially bioavailable amounts. This parameter can be determined with in vivo studies on animal 
models, but such studies are expensive, time-consuming and ethically critical. Therefore, several in 
vitro approaches have been developed in attempts to mimic the effects of the human-digestion 
process [12]. Such approaches are in agreement with the well-known “Three Rs” principle, which 
involves: i) Replacing the use of animals with alternative techniques, or avoid the use of animals 
altogether; ii) Reducing the number of animals used to a minimum; iii) Refining the way 
experiments are carried out, to make sure animals suffer as little as possible [13]. “Three Rs” 
principle is the basis of Directive 2010/63/EU, revising Directive 86/609/EEC on the protection of 
animals used for scientific purposes [14]. 
The gastrointestinal digestive processes are quite complicated and difficult to simulate in vitro. A 
number of different models is based on extraction with solutions simulating the effect of gastric 
and intestinal fluids [11, 12]. Several studies in the area of human nutrition have reported in vitro 
methods to assess bioavailable iron in foodstuffs [15, 16]. In addition, some approaches include 
the addition of food constituents to the extractant, since food constituents (e.g. milk, bread and 
starch) can affect the fraction of the contaminant released into the digestive fluids during transit 
through the gastrointestinal tract after ingestion [17, 18]. Similar tests are also used for testing the 
oral bioaccessibility of soil contaminants upon soil ingestion, see e.g. [19-22], and the methods 
have been reviewed [23, 24]. Table 1 summarizes the characteristics of some popular simulated 
gastrointestinal extraction methods; as it can be seen, such methods are referred to with different 
names: i) physiologically-based extraction test (PBET) [25]; ii) Simple Bioaccessibility Extraction Test 
(SBET) [24, 26, 27]; iii) In vitro digestion model, by the National Institute of Public Health and the 
Environment (RIVM, The Netherland) [11, 20] , iv) Simulator of Human Intestinal Microbial 
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Ecosystem of Infants (SHIME) [11, 28]; v) TNO Gastro-Intestinal Model (TIM; TNO: The Netherlands 
Organization for Applied Scientific Research) [11, 29]; vi) the German standard method for 
absorption availability of organic and inorganic pollutants from contaminated soil material 
(Deutsches Institut für Normung - DIN E 19738 method) [30, 31]. These methods have 
demonstrated good correlation with in vivo tests in some studies [25, 11, 24, 32]. However, there is 
still a lack of information regarding the behavior of contaminants and materials, and research is in 
progress to identify a common and accepted test method in view of an international 
standardization [24, 32]. Despite the large number of studies on bioaccessibility of PTEs in soils and 
food, few papers deal with this topic in ayurvedic formulations [33-36] and in traditional Chinese 
medicines [37-42]. Attention was mainly focused on the behavior of As and Hg, owing to their high 
toxicity, but studies on other elements such as Cd, Cu, Fe, Mn and Zn are also available. Conversely, 
Yan et al. assessed the effect of traditional Chinese medicines on the bioaccessibility and 
speciation of As and Hg [38]. 
In a previous study we compared the characteristics of ayurvedic medicines purchased from 
different commercial channels and studied bioaccessibility with single extraction tests [36]. 
In this work, after the evaluation of the total PTE content in a set of ayurvedic products purchased 
in India, we estimated the bioaccessibility of the analytes by in vitro sequential extractions with 
synthetic gastric and intestinal fluids. We also applied modifications to the experimental procedure 
to assess the influence of changing of operative conditions on the final results. Finally, the 
concentration of each analyte was compared with established acceptable daily intake values for 
metal ingestion indicated by the guidelines of international organizations. 
 
2. Material and methods 
2.1. Samples and sample pretreatment 
Unfortunately, no reference materials for ayurvedic medicines are available on the market. Two 
Certified Reference Materials (CRMs), namely Tomato Leaves SRM 1573a, and Saint Joaquin Soil 
2709 supplied by the National Institute of Standards and Technology (NIST), were analysed to value 
the efficiency and the accuracy of analyte quantification. 
Nine ayurvedic formulations were purchased in India. The name of the products, the ingredients 
declared on the label and the aspect of formulations are summarized in Table 2. The purchased 
samples appeared as powder (seven products) or gel (two specimens). All the samples were 
analyzed without any pretreatment. 
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2.2. Apparatus and reagents 
Sample dissolution was performed in polytetrafluoroethylene (PTFE) bombs, with a Milestone 
ETHOS-One (Milestone, Sorisole, Italy) microwave laboratory unit. Most of the analyses were 
carried out with a Perkin Elmer Optima 7000 (Perkin Elmer, Norwalk, Connecticut, USA) inductively 
coupled plasma-optical emission spectrometer (ICP-OES). For the determination of element 
concentrations lower than the Limit of Quantification (LoQ) of ICP-OES, a Perkin Elmer Analyst 600 
(Perkin Elmer, Norwalk, Connecticut, USA) graphite furnace equipped-atomic absorption 
spectrometer (GF-AAS) was used. 
Standard metal solutions were prepared from concentrated stock solutions (Sigma Aldrich, 
Darmstadt, Germany). 
High purity water (HPW) produced with Millipore Milli-Q system was used throughout. The 
reagents adopted were of analytical grade. 
Two of the bioaccessibility tests performed (see section 2.3) were conducted with the aid of 
dialysis tubes (Sigma Aldrich). 
The gastric juice was prepared by dissolving 2.0 g of NaCl in 7.0 mL of HCl. The solution was  
diluted to 1000 mL with HPW ad the pH adjusted to the final value of 1.2. 
The intestinal medium was obtained by dissolving 6.8 g of KH2PO4 in 250 mL of HPW; then 77.0 mL 
of 0.2 N NaOH and 500 mL of HPW were added; finally pH was adjusted to 6.8 with the aid of 0.2 N 
NaOH or 0.2 N HCl and the solution was diluted to 1000 mL with HPW. 
 
2.3. Procedures 
2.3.1. Determination of the total element content 
Acid digestion in the microwave oven was adopted to dissolve the samples. Aliquots of 0.5 g of 
each ayurvedic medicine were treated with 6 mL of HNO3 and 2 mL of H2O2 in PTFE bombs. After 
the heating and ventilation steps, the resulting solutions were filtered on Whatman 5 filters and 
then diluted to 30 mL with HPW. The solutions were directly employed for ICP-OES or GF-AAS 
analysis, depending on the analyte concentration level. In both cases, the calibrations were 
performed with standard solutions prepared in aliquots of sample blanks diluted in the same ratios 
as the sample solutions. Standard solutions were periodically analyzed and their signals were used 
to correct the sample signals for drift of instrumental sensitivity. The limits of detection (LoD) and 
7 
the LoQ were estimated as three and ten times the standard deviation of the blank respectively. 
Tables in this paper report LoQ values. 
In order to check the accuracy of the experimental procedure Tomato Leaves SRM 1573a and Saint 
Joaquin Soil 2709 were analyzed to assess the effect of vegetal and mineral matrices on element 
determination respectively. Among the certified elements, we considered for Tomato Leaves SRM 
1573a Cr (1.99 ± 0.06 mg/kg), Cu (4.70 ± 0.14 mg/kg), Hg (0.034 ± 0.004 mg/kg), Mn (246 ± 8 
mg/kg), and for Saint Joaquin Soil 2709 As (17.7 ± 0.8 mg/kg), Hg (1.4 ± 0.08 mg/kg) and Pb (18.9 ± 
0-5 mg/kg). The recoveries ranged between 93 and 108% for all analytes with the exception of Cr 
(76%) and Pb (87%). 
 
2.3.2. Determination of the bioaccessible content 
Different procedures were adopted to value the bioaccessible fraction [43]. 
Method A. 0.2 g aliquots of ayurvedic product were subjected to two sequential steps: i) extraction 
with 25 mL of gastric medium for 2 h; ii) extraction with 25 mL of intestinal medium for 6 h. During 
each step the suspensions were maintained at the temperature of 37 °C, shaking periodically to 
mimic peristaltic motions of stomach and intestine. After the first extraction, the suspension was 
subjected to centrifugation for 10 min at 4,000 rpm. The solution was separated, filtered on 
Whatman 5 filter and analyzed, while the solid residue (from step i) underwent the second 
extraction step. All experiments were performed in triplicate.  
Method B. The same procedure as described for Method A was followed, but the sample was 
mixed with 1 g of ghee (traditional Indian clarified butter). 
Method C. Aliquots of 0.2 g of each samples were transferred into a piece of membrane for dialysis 
in the form of a tube (length: 10 cm) with 1 mL of HPW. Then the tube was closed at both ends and 
put in contact with 25 mL of gastric medium for 2 h at 37 °C and shaken periodically. After 
extraction the tube was removed from the solution and dipped in 25 mL of intestinal medium for 6 
h. Then both extracting solutions were analyzed. 
Method D. The same procedure as reported for Method C was followed, but the sample was mixed 
with 1 g of ghee. 
 
2.3.3. Chemometric treatments 
Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) were carried out with 
the aid of XLSTAT4.4 software package, used as a Microsoft Excel plug-in. Unscrambler X 10:2 was 
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employed for data standardization, obtained by mean-centering (for each variable) and dividing by 
the corresponding standard deviation, and for substituting values below LoQs with estimated 
values. The Euclidean distance and Ward’s agglomeration method were used for HCA. 
 
3. Results and discussion 
3.1. Total concentrations 
Among PTEs, attention was focused onto As, Cu, Cr, Hg, Mn and Pb content taking into account the 
results of a preliminary semiquantitative analysis of the investigated medicines and our knowledge 
on their composition [44]. Table 3 shows the total concentrations of the analytes in each product.  
Overall, samples 5-9 have higher concentrations of the selected PTEs than samples 1-4, with 
sample 4 having higher analyte levels than specimens 1-3. Some products have outstandingly high 
concentrations of As (5 and 6), Cu (7 and 8), Hg (5-9) and Pb (9). This trend was not unexpected, 
considering the available information on sample composition, reported in the Introduction, and 
the names of some samples: Talaka or Thalaka means “arsenic” (samples 5 and 6), Tamra means 
“copper” (sample 7). 
The dataset was processed with chemometric pattern recognition techniques, so as to obtain an 
overview of the results and visualize similarities and differences among the investigated medicines. 
Figure 1 shows the combined plot of scores and loadings resulting from PCA and the dendrogram 
obtained by HCA. As to scores (Figure 1a), samples 1-4 are grouped together, owing to the 
relatively low content of the analytes. The position of the other products indicates the element 
prevailing in their composition: As for samples 5 and 6, which are closely clustered, Cu, Pb and Hg 
for samples 7, 8, 9 respectively. The results of HCA (Figure 1b) show an analogue clustering of the 
medicines. Pearson’s correlation matrix (not shown) indicates that there is only a correlation 
between Mn, Cr and Pb; the cause of this relationship is difficult to explain. Variable correlations 
usually indicate the presence of a common origin or a similar chemical behavior in a sample 
matrix: this is true for instance in environmental samples, but it is not valid for ayurvedic 
medicines, in which elements are intentionally added by manufacturers. For this reason As, Cu and 
Hg are not correlated to other elements. Therefore, in the present study pattern recognition 
techniques are useful to distinguish different groups of formulations, but provide little information 
on the behavior of their components. 
The interpretation of these results can be aided by comparing the intake of each considered 
element upon consumption of ayurvedic medicines with tolerable levels issued by international 
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organisms (Table 4). When possible, we adopted the values issued by the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA); as to the elements for which no JECFA values existed, we 
referred to the levels established by the Agency for Toxic Substances and Disease Registry (ATSDR, 
USA) or, for Mn, by the European Food Safety Authority (EFSA). In the case of Pb, JECFA has 
withdrawn a previously established tolerable intake level, stating that it is not possible to provide a 
new value that would be considered health-protective. Anyway, since no values from ATSDR or 
other institutions are available for Pb (to the best of our knowledge), we referred to the withdrawn 
level: of course the conclusions reached for this element must be considered just indicative and 
regarded with great caution. The daily intake was calculated from element concentration and the 
posology of each medicine reported in the leaflet or taken from the literature. To simplify the 
comparison, all tolerable levels were converted to the same unit, i.e. mg per day for an average 
body weight of 60 kg. Table 4 shows that most samples, with the exception of specimens 3 and 4, 
exceed one or more tolerable intake level. Obviously the extent of exceedance is particularly 
dramatic for samples 5-9. For this reason, we decided to gain insight into the actual possible 
uptake of PTE in such samples, and consequently the risks for consumers, with the aid of in vitro 
studies. 
 
3.2. Bioaccessible concentrations 
3.2.1. Element extractability in synthetic gastric and intestinal juices 
The bioaccessibility of the investigated elements in samples 5-9 was estimated by extraction with 
solutions simulating gastric and intestinal juices, following Method A (section 2.3.2). In our 
previous paper [36] we performed single extractions, in order to assess the extracting efficiency of 
each medium on fresh sample aliquots. In the present study we made two sequential extractions, 
as prescribed by the American Pharmacopoeia [43]. The results are reported in Table 5, in terms of 
both concentrations and extraction percentages. 
We did not add enzymes, as we observed in previous experiments that the extraction efficiency of 
the reagents towards metals were not influenced by these reagents, which have other roles in our 
organism. The results confirm our earlier findings that extraction mainly takes place in the gastric 
medium, thanks to its acidic pH, which favors the dissolution of hydroxides and oxides of metals 
and the breakage of the bonds between metals and organic components of the medicines [36]. 
The bioaccessibility data do not show a definite trend, either as a function of an element or as a 
function of a sample. The chemical form and behavior of the elements, such as the solubility of 
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their salts at the working pH, is probably the main factor influencing the results. All the 
investigated samples are in the form of powders, i.e. they are in close contact with the extractants: 
so the form of the product is not a cause of the different behavior of the samples; in the next step 
of our study we plan to compare the behavior of the same product in the form of entire tablet and 
powder.  
Figure 2 shows the combined plot of scores and loadings resulting from PCA and the dendrogram 
obtained by HCA applied to bioaccessible concentrations. As observed for total amounts samples 5 
and 6 are differentiated from the other ones owing to the high concentration of As. Again sample 9 
has very different characteristics from the other ones. 
 
3.2.2. Influence of operating conditions  
The results of bioaccessibility studies depend on the procedure adopted, not only from the point 
of view of the composition of the extracting fluids, but also for the effect of the operative 
conditions. This is a main drawback of investigations based on single and sequential extraction also 
in other fields, e.g. in the evaluation of element mobility in soils [24].  
One of the main parameters affecting in vitro bioaccessibility tests is surely the extent of the 
contact between sample and extracting solution. For this reason we carried out the extractions in 
different conditions. 
Many of the investigated samples must be swallowed with honey or with ghee, the typical Indian 
butter. For this reason we investigated the effect of ghee on element bioaccessibility according to 
Method B (section 2.2.3). We performed these experiments with samples 5, 6 and 7. Table 6 shows 
that the amount of extracted elements decrease in the presence of ghee. This results might be due 
to the fact that the hydrophobic nature of butter and the lowest surface area of the sample after 
mixing with ghee reduce its contact with the extractant. 
We finally tested a different approach to expose the sample to the fluids, using specimen 6 as a 
probe. We inserted the powder into tubes made of membrane for dialysis. The advantage of this 
procedure is that the centrifugation and filtration steps after extraction are avoided, thus reducing 
the risk of sample losses, since the specimen is just transferred from the gastric to the intestinal 
medium. This experiment was performed both without and with ghee, according to Method C and 
D respectively (section 2.2.3). The results, summarized in Table 7, show that element extractability 
decreases when the sample is inside the membrane. This might be again due to a less extensive 
contact between the sample and the solution, but also to a low transfer of ions through the pores 
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of the membrane. So the use of this procedure requires a further optimization, to avoid an 
underestimation of bioaccessibility. We plan to perform further experiments and monitor the 
extent of extraction as a function of time, since longer times might be required for a complete 
extraction. Table 7 also shows that  mixing with ghee causes a reduction of PTEs extractability, 
confirming the trend discussed above. This finding suggests that the traditional indication of 
assuming the medicines with ghee might be meaningful. 
 
3.2.3. Comparison with reference values 
As we made with total concentrations, we compared daily intake levels, computed from 
bioaccessible concentrations, with tolerable reference levels. Table 8 shows that the number of 
intake values higher than the limits is greatly decreased in comparison to Table 4. Therefore, 
considering the total or bioaccessible concentrations leads to different conclusions regarding the 
potential toxicity of a product.  
 
4. Conclusions 
Our study confirms that some ayurvedic medicines have very high concentrations of PTEs, 
intentionally added according to the tradition. Anyway, many ayurvedic formulations are herb-
based and do not pose any threat to health, at least from the point of view of the metal content. 
Therefore it is important that consumers of these medicines consult experts in Ayurveda to choose 
safe products. 
To be marketed in Western countries, ayurvedic medicines have to be declared “metal free”. So 
only herb-based ayurvedic products can be sold in Italy. In our previous study [36] we had analyzed 
medicines bought in an Italian farmacy, and found that they complied with the legislation.   
Bioaccessibility studies showed that only a part of the total content is soluble in synthetic gastric 
and intestinal fluids: the bioaccessible fraction was found to be different for the same element in 
different products, so it is probably related to the chemical form of the element, e.g. on the 
solubility of its salt, and on the components of the sample matrix.  
The procedure adopted for extraction has a strong influence on the release of the elements from 
the medicines: therefore it is important to homogenize the protocol adopted in different 
laboratories, so that data can be comparable. 
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Captions to figures 
Figure 1. Combined plot of scores and loadings obtained by PCA (a) and dendrogram obtained by 
HCA (b) for total element concentrations. 
 
Figure 2. Combined plot of scores and loadings obtained by PCA (a) and dendrogram obtained by 
HCA (b) for bioaccessible element concentrations. 
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Table 1 
Some in vitro methods reported for the evaluation of bioaccessibility. 
 
Method1 
Sample 
weight2 
Oral cavity (saliva) Stomach (gastric juice) Intestine (intestinal juice) 
PBET [25] 0.4 g - 
For 1 L of extracting medium: 0.50 g 
citrate, 0.50 g malate, 420 µg lactic acid, 
500 µg acetic acid, pepsin 
pH = 2.5 (40 mL, 60 min) 
40 ml gastric juice adjusted to pH 7.0, 70 g 
mg bile salt, 20 mg panchreatin  
(40 mL, 180 min) 
SBET [24,26,27] 1 g - 
0.4 M glycine 
pH = 1.5 (100 mL, 60 min)  
- 
In vitro digestion model3 
[11,20] 
0.6 g 
KCl, KSCN, NaH2PO4, 
Na3PO4, NaCl, urea, -
amylase, uric acid, mucin 
pH = 6.5 (9 mL, 5 min)3 
NaCl, NaH2PO4, KCl, CaCl2.2H2O, NH4Cl, 
HCl, glucose, glucuronic acid, urea, 
glucoseamine hydrochloride, bovine 
serum albumin, pepsin, mucin  
pH = 1.1(13,5 mL, 120 min) 
 
Duodenal juice (NaCL, NaHCO3, KH2PO4, 
KCl, MgCl2, HCl, urea, , CaCl2.2H2O, bovine 
serum albumin, pancreatin, lipase 
pH 7.8 
Bile (NaCl, NaHCO3, KCl, HCl, urea, 
CaCl2.2H2O, bovine serum albumin, bile 
(chicken-) 
pH 8.0 
(27 mL duodenal fluids, 9 ml bile, 120 min) 
SHIME 
[11,28] 
10 g - 
For 1 L of extracting medium: 15 g 
Nutrilon (commercial baby food), 16 g 
pectine, 8 g mucin, 5 g starch, 1 g 
cellobiose, 1 g glucose, 1 g proteose 
peptone, 18 ml milk cream  
pH = 4.0 (25 mL. 180 min) 
Pancreatic fluid. For 1 L of extracting 
medium: 12 g NaHCO3, 4 g bovine bile, 0.9 
g pancreatine 
pH = 6.5 (15 mL, 300 min) 
TIM4 
[11,29] 
 
Electrolytes, -amylase pH = 
5.0 (50 mL, 5 min) 
Electrolytes, pepsin, lipasepH decreasing 
from  5.0 to2.0, (250 mL, 90 min) 
Electrolytes, bile and pancreatin pH 
increasing from 6.5 to7.2 (210 mL, 360 
min) 
  
Table 1 (continued) 
Method1 
Sample 
weight2 
Oral cavity (saliva) Stomach (gastric juice) Intestine (intestinal juice) 
E DIN 19738 [30,31]  - 
For 1 L of extracting medium: 2.9 g NaCl, 
0.7 g KCl, 0.27 g KH2PO4, pepsin, mucin  
pH = 2.0 (100 mL, 120 min) 
Porcine bile, trypsin, pancreatin pH = 7.5 
(100 mL, 360 min)  
 
1 PBET: Physiologically Based Extraction Test [25]; SBET: Simplified Bioaccessibility Extraction Test [24] or Simple bioavailability extraction test [26] or Simple 
Bioaccessibility Extraction Test [27]; SHIME: Simulator of Human Intestinal Microbial Ecosystem of Infants [11,28]; TIM: TNO Gastro-Intestinal Model (TNO: The 
Netherlands Organization for Applied Scientific Research) [11,29]; DIN: Deutsches Institut für Normung. Standard method: Soil quality — absorption availability 
of organic and inorganic pollutants from contaminated soil material [30,31].  
2 Sample weights are expressed as dry weight 
3 Details on the amount of each constituent are reported in ref. [20] 
4 TIM is a dynamic multi-compartmental apparatus, simulating conditions of the gastro-intestinal tract, which can be used with different extracting media. Data 
reported for saliva, gastric and intestinal juice are taken from ref. [29] 
 
  
  
Table 2 
Characteristics of the investigated samples. 
 
Sample Id. Sample name Ingredients Aspect Uses and posology 
1 
ASHWAGANDHI 
LEGIYAM 
Ashwagandhi (Seemai Amakkar, Withania somnifera), Thiratchai (Vitis vinifera), Seeragam 
(Cuminum cyminum), Pareechu (phonex dactylifera), Sandanam (Sandalum album), Jadhikkai 
(Myristica fragrans), Korai Kizhangu (Cyprus rotundus), Kadukkaithol (Rhus succidina), Kokkaineer 
(Marntana aurundiracea), Chukku (Zingiber officinale), Milagu (Piper nigrum), Thippili (Piper 
longum), Vilamichanver (Cymbopogan jwarangusa), Kirambu (Syzigium aromaticum), Sevviyam 
(Piper nigrum, radice), Chithiramoolam (Plumbago zeylanica), Lavanga Pattai (Cinnamon 
zeylanicum), Sirunagapoo (Cynnammon verum), Sarkkai (Saccharum officinuram). Milk, Pasunei 
(ghee) 
Brown gel 
Anemia, lack of appetite, 
icterus: improvement of 
well-being in general. 
3 -6 g with milk, twice a 
day 
2 
THIPPILI 
RASAYANAM 
Thippili (Piper longum), Chukku (Zingiber officinale), Milagu (Piper nigrum), Seeragam (Cumium 
cyminum), Karum Seeragam (Nigella sativa), Omum (Trachyspermum ammi), Sitraraththai (Alpina 
calcarata), Peraraththai (Alpina galanga), Kaddukai (Terminalia chebula), Nellikkai (Emblica 
officinalis), Thaanrikkai (Terminalia belerica), Lavangam (Syzygium aromaticum), Lavanga paththiri 
(Cinnammomum tamala), Thaaleesa paththiri (Taxus baccata), Kodiveli. Ver Pattai (Plumbago 
indica), Elakkai (Eletteria cardamomum), Lavanga Pattai (Cinnamomum cassia), Sarkkarai 
(Saccharum officinarum). Thein (honey) 
Green gel 
Cough, cold, hemoptysis, 
bronchitis, lung disease, 
dyspnea, diarrhea. 
5 - 10 g with milk or ghee, 
twice a day 
 
3 
THAALEESRADHI 
CHOORANAM 
Thaaleespatra (Abies webbiana), Milagu (Piper nigrum), Chukku (Zingiber officinale), Thippili (Piper 
nigrum), Lavanga Pattai (Cinnamomum zeylanicum), Elakkai (Elettaria cardammomum), Sarkkarai 
(Saccharum officinuram) 
Pale brown 
powder 
Cough, cold, congestion. 
1 - 5 g with honey or hot 
water 
4 
PAVAZHA 
PARPAM 
Corals, rabbit blood 
Fine white 
powder 
Anemia, anorexia, 
emesis, burning 
sensation. 
100 - 200 mg with milk or 
ghee, , twice a day 
5 
THALAKA 
CHENDURAM 
Appala karam, Padikaram, Paththira thalakam (Suththi seithathu) 
Fine yellow 
powder 
Urinary tract infection.  
50 - 100 mg with milk or 
ghee, twice a day  
  
  
Table 2. Continued 
 
Sample Id. Sample name Ingredients Aspect Uses and posology 
6 TALAKA 
BHASMA 
Talaka, Karavalli svarasa, Palasa tvak ksata Fine green-
brown 
powder 
Astringent, 
antispasmodic; cough 
soother; hepatic 
disorders  
65 - 130 mg with honey, 
once a day 
7 
THAMBIRA 
PARPAM 
Suththi seitha thaamira thakadu or paththram, Induppu, Elumichcham pazha saru, Adutheenda 
palai saru, Azhinjil ver kiyazham 
Fine black 
powder 
Astringent, 
antispasmodic; ulcer 
3 mg/Kg 
with honey and ghee 
once a day 
8 
PANCHAMRIT 
PARPATI 
Thambra bhasma (copper), Abhraka bhasma (mica), Loha bhasma (iron), Shudda bhasma 
(mercury), Shudda gandhaka (sulfur) 
Fine black/ 
brown 
powder 
Anorexia, diarrhea, 
discomfort in general, 
eye diseases 
125 - 500 mg 
twice a day. 
9 
JAHARMOHRA 
KATAI PISTI 
Not reported 
Grey 
powder 
Tonic; palpitation, 
spasms, tetanus, 
hypertension 
200 - 400 mg 
twice a day 
 
 
 
 
  
 
Table 3 
Total concentrations of As, Cr, Cu, Hg, Mn and Pb in the investigated samples (mg/kg). 
 
Sample As Cr Cu Hg Mn Pb 
1 ≤ 1.3 ≤ 0.1 1.7 ± 3.3 3.6 ± 1.8 8.4 ± 1.2 0.6  
2 1.1 ± 0.2 ≤ 0.1 3.2 ± 0.1 2.0 ± 0.04 53.0 ± 1.0 1.8 ± 0.4 
3 ≤ 1.3 ≤ 0.1 1.1 ± 0.01 ≤ 1.0 42.7 ± 0.4 0.5 ± 0.1 
4 19.1 ± 1.1 7.0 ± 0.7 0.6 ± 0. 1 5.3 ± 0.2 41.7 ± 2.6 0.7 ± 0.1 
5 419000 ± 600 6.7 ± 0.1 26.7 ± 0.5 253 ± 3 36.4 ± 0.1 12.5 ± 0.1 
6 479000 ± 4000 6.0 ± 0.2 56.2 ± 0.2 126 ± 2 18.9 ± 0.8 37.3 ± 0.3 
7 45.8 ± 4.6 28.6 ± 0.4 675000 ± 1600 161 ± 2 197 ± 6 132 ± 1 
8 567 ± 31 11.8 ± 0.3 21400 ± 9200 15600 ± 1500 168 ± 1 3.2 ± 3.6 
9 19.1 ± 2.9 643 ± 25 81.0 ± 4.0 109 ± 5 243 ± 4 248 ± 13 
 
 
 
  
  
Table 4 
Comparison of tolerable uptake levels with the amounts of PTEs ingested following the posology of each product. The values are expressed as mg/day for a 60 
kg individual. Element intakes exceeding the reference levels are written in boldface. 
 
Sample Dose As Cr Cu Hg Mn Pb 
1 
Min. - - 0.017 0.036 0.084  0.006 
Max. - - 0.034 0.072 0.168  0.012 
2 
Min. 0.007 - 0.019 0.012 0.318 0.011 
Max. 0.014 - 0.038 0.024 0.636 0.021 
3 
Min. - - 0.002 - 0.085 0.001 
Max. - - 0.011 - 0.427  0.005 
4 
Min. 0.004 0.001 1.3∙10-4 0.001 0.008 1∙10-4  
Max. 0.008 0.003 2.6∙10-4 0.002 0.017 3∙10-4  
5 
Min. 42 6.66∙10-4 0.003 0.025 0.004 0.001 
Max. 84 0.001 0.005 0.051 0.007 0.002 
6 
Min. 31 3.9 10- 0.004 0.008 0.001 0.002 
Max. 62 7.8 10-4 0.007 0.016 0.002 0.005 
7  0.008 0.005 122 0.029 0.035 0.024 
8 
Min. 0.142 0.003 5.35 4 0.042 8∙10-4  
Max. 0.567 0.012 21.4 16 0.168 0.003 
9 
Min. 0.008 0.257 0.032 0.044 0.097 0.099 
Max. 0.015 0.514 0.065 0.087 0.194 0.198 
Tolerable level1,2  0.018 0.05  30  0.034  3  0.21 
1Acronyms for institutions and tolerable levels: Agency for Toxic Substances and Disease Registry: ATSDR; European Food 
Safety Authority:EFSA; Joint FAO/WHO Expert Committee on Food Additives: JECFA; Minimal Risk Levels: MRLs; Provisional 
Maximum Tolerable Daily Intake: PMTDI; Provisional Tolerable Weekly Intake: PTWI; Tolerable Daily Intake: TDI 
2Sources and original values of tolerable levels: As: 3.10-4 mg/kg bw/day (MRL issued by ATSDR); Cr(VI): 9.10-4 mg/kg bw/day 
(MRL for chronic toxicity issued by ATSDR); Cu: 0.5 mg/kg bw/day (PMTDI issued by JECFA); Hg: 4 µg/kg bw/week (PTWI 
issued by JECFA); Mn; 0,05 mg/kg bw/day (TDI, issued by EFSA); Pb: 0,025 mg/kg bw/week (PWTI previously issued by JEFCA 
and now withdrawn).  
  
Table 5 
Concentrations (mg/kg) and percentages of bioaccessible elements in selected ayurvedic products. GM = gastric medium; IM = intestinal medium 
 
Sample – 
Medium 
Unit As Cr Cu Hg Mn Pb 
5 – GM mg/kg 144000 ± 4000 1.46 ± 0.11 2.31 ± 0.52 11.9 ± 0.3 26.8 ± 0.5 0.64 ± 0.01 
 % 34.4 ± 1.0 21.9 ± 1.7 8.7 ± 1.9 4.7 ± 0.1 73.6 ± 1.4 5.1 ± 0.1 
5 – IM mg/kg 388 ± 50 ≤ 0.12 0.33± 0.10 ≤ 0.10 0.47 ± 0.01 ≤ 0.10  
 % 0.1 ± 0.01 - 1.2 ± 0.4 - 1.3 ± 0.03 - 
6 – GM mg/kg 29600 ± 3900 1.18 ± 0.35 2.73 ± 0.06 4.311 9.35± 0.72 10.3± 1.6 
 % 6.2 ± 0.8 19.6 ± 0.9 4.8 ± 0.1 0.1 49.5 ± 3.8 27.6 ± 4.2 
6 – IM mg/kg 21700 ± 1600 0.26 ± 0.18 1.88 ± 0.13 ≤ 0.10  1.07 ± 0.14 ≤ 0.10 
 % 4.5 ± 0.3 4.3 ± 2.9 3.3 ± 0.2 - 5.7 ± 0.8 - 
7 – GM mg/kg 43.0 ± 0.6 0.97 ± 0.19 1341 ± 99 103 ± 7 12.1 ± 1.0 9.151 
 % 93.9 ± 1.3 3.4 ± 0.7 0.2 ± 0.01 64.0 ± 4.4 6.1 ± 0.5 3.3 
7 – IM mg/kg 0.42 ± 0.14 ≤ 0.12- ≤ 0.30 4.89 ± 0.43 0.55 ± 0.32 0.16 ± 0.08 
 % 0.9 ± 0.3 - - 3.0 ± 0.3 0.3 ± 0.2 0.1 ± 0.06 
8 – GM mg/kg 437 ± 42 6.39 ± 0.17 519 ± 9 326 ± 5 9.89 ± 0.70 2.17± 0.32 
 % 77.1 ± 7.4 54.2 ± 1.5 2.4 ± 0.04 2.1 ± 0.03 5.9 ± 0.4 67.0 ± 10.0 
8 – IM mg/kg 87.2 ± 0.04 1.13± 0.002 22.0 ± 0.3 ≤ 0.10  0.84 ± 0.001 0.12± 0.0002 
 % 15.4 ± 0.01 9.6 ± 0.02 0.1 ± 0.001 - 0.5 ± 0.001 3.7 ± 0.01 
9 – GM mg/kg 3.68 ± 0.18 25.1 ± 2.1 34.2 ± 6.1 44.8 ± 1.2 93.1 ± 1.7 246 ± 5 
 % 19.3 ± 0.9 3.9 ± 0.3 42.2 ± 7.5 41.1 ± 1.1 38.3 ± 0.7 99.2 ± 2.0 
9 – IM mg/kg 1.45 ± 0.16 4.16 ± 0.32 1.27 ± 1.16 ≤ 0.10  2.35 ± 0.42 ≤ 0.10 
 % 7.6 ± 0.8 0.6 ± 0.05 1.6 ± 1.4 - 1.0 ± 0.2 - 
1The concentrations of Hg in sample 6 (GM) and Pb in sample 7 (GM) were detectable only in one of the investigated specimens, 
owing to the heterogeneity of the material, as observed in our previous studies [44]. 
  
Table 6 
Concentrations (mg/kg) and percentages of bioaccessible elements in selected ayurvedic products after mixing with ghee.  
GM = gastric medium; IM = intestinal medium. 
 
Sample Medium 
As Cr Cu Hg Mn Pb 
mg/kg % mg/kg % mg/kg % mg/kg % mg/kg % mg/kg % 
5 GM 9469 2.3 ≤ 0.05 - 1.54 5.8 2.97 24.9 0.52 1.4 ≤ 0.10 - 
 IM 406 1.0 ≤ 0.05 - 0.16 0.6 7.99 3.2 0.35 1.0 ≤ 0.10 - 
6 GM 526 0.1 0.07 1.2 2.58 4.6 11.7 9.3 2.58 13.6 ≤ 0.10 - 
 IM 483 0.1 1.8 0.02 1.8 3.2 ≤ 0.10 - 0.12 0.7 ≤ 0.10 - 
7 GM 7.22 15.8 ≤ 0.05 - 6757 1.0 0.71 0.5 3.99 2.0 1.52 0.6 
 IM 3.11 6.8 ≤ 0.05 - 5727 0.8 0.28 0.2 0.75 0.8 ≤ 0.10 - 
 
 
  
  
 
Table 7 
Percentages and concentrations of bioaccessible elements in sample 6 (Talaka Bhasma) inserted in a dialysis tube, with ghee (“Dialysis + ghee”) and without it 
(“Dialysis”) . GM = gastric medium; IM = intestinal medium. 
 
Procedure  As Cr Cu Hg Mn Pb 
  mg/kg % mg/kg % mg/kg % mg/kg % mg/kg % mg/kg % 
Dialysis GM 23500 4.9 0.68 11.1 3.69 6.6 2.51 2.0 8.19 43.3 15.3 41.9 
 IM 8060 1.7 0.18 2.9 2.62 4.7 0.25 0.2 2.00 10.6 2.85 7.6 
Dialysis + ghee GM 543 0,1 ≤ 0.05 - - 1,95 3,5 1,68 1,3 2,58 13,6 ≤ 0.10  - 
 IM 483 0,1 ≤ 0.05  - 1,81 3,2 ≤ 0.10 - 0,12 0,7 ≤ 0.10  - 
 
 
 
  
  
Table 8 
Elements exceeding the tolerable reference levels. Element intakes upon consumption of product 6 were calculated from bioaccessible concentrations. 
Tolerable levels are expressed in mg/day for a 60 kg individual. GM = gastric medium; IM = intestinal medium. 
 
Procedure As Cr Cu Hg Mn Pb 
Method A 
Sample 5 (min and max), GM 
Sample 6 (min and max), GM 
Sample 6 (min and max). IM 
- - 
Sample 7, GM 
Sample 8 (min and max), GM 
Sample 9 (min and max), GM 
- - 
Method B Sample 5 (min and max), GM - - - - - 
Method C Sample 5 (min and max), GM - - - - - 
Method D - - - - - - 
Tolerable level 0.018 0.05  30  0.034  3  0.21  
 
 
